EUVIMEDEUVIMED entdecken
MetaanalyseOpen Access · CC BY-NC-ND 4.0

Left atrial appendage occlusion versus oral anticoagulation for stroke prevention in atrial fibrillation: A meta-analysis of randomized controlled trials

Avilash Mondal, Sittinun Thangjui, Abhiram Challa, Banveet Kaur, Syed Mufarrih Hamza, Vien Truong, Amro Taha, Harshith Thyagaturu, Giorgi Chilingarashvili, Alison Bailey, Muhammad Bilal Munir, David Schwartzman und 1 weitere

Indian Journal of Cardiology · 2026-01 · 29 (1) · 68-78

DOI: 10.4103/ijoc.ijoc_15_26 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Indian Journal of Cardiology, online erschienen am 08.08.2026. Verfasst von Avilash Mondal und 12 weiteren Autor:innen. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Randomised controlled trials comparing percutaneous left atrial appendage occlusion (LAAO) with oral anticoagulation (OAC) for stroke prevention in atrial fibrillation (AF) have reported mixed results. We conducted a systematic review and meta-analysis of randomised controlled trials comparing LAAO with OAC in patients with non-valvular AF. Prespecified outcomes included the composite of stroke, systemic embolism, or cardiovascular death; ischaemic, haemorrhagic, disabling, non-disabling, and all stroke; cardiovascular and all-cause mortality; non-procedural and total major bleeding; and pericardial effusion or tamponade. Random-effects models were used to pool log-transformed hazard ratios (HRs) with 95% confidence intervals (CIs). Six trials comprising 7004 patients were included. LAAO was not associated with a significant difference in the composite outcome of stroke, systemic embolism, or cardiovascular death compared with OAC (HR, 1.00; 95% CI, 0.83–1.21; I 2 = 30.8%). LAAO was associated with a higher risk of ischaemic stroke (HR, 1.44; 95% CI, 1.06–1.95; I 2 = 0%) and a lower risk of non-procedural major bleeding (HR, 0.55; 95% CI, 0.40–0.74), whereas total major bleeding did not differ significantly between groups (HR, 0.94; 95% CI, 0.79–1.11). Exploratory Bayesian analyses showed a high posterior probability of harm for ischaemic stroke and strong support for a reduction in non-procedural major bleeding. LAAO therefore demonstrated similar overall composite efficacy to OAC but was associated with increased ischaemic stroke and reduced non-procedural major bleeding, without a significant difference in total major bleeding. These competing effects should be explicitly considered during shared decision-making.

Zitieren

APA

Mondal, A., Thangjui, S., Challa, A., Kaur, B., Hamza, S. M., Truong, V., Taha, A., Thyagaturu, H., Chilingarashvili, G., Bailey, A., Munir, M. B., Schwartzman, D., & Balla, S. (2026). Left atrial appendage occlusion versus oral anticoagulation for stroke prevention in atrial fibrillation: A meta-analysis of randomized controlled trials. Indian Journal of Cardiology, 29(1), 68-78. https://doi.org/10.4103/ijoc.ijoc_15_26

Vancouver

Mondal A, Thangjui S, Challa A, Kaur B, Hamza SM, Truong V, et al. Left atrial appendage occlusion versus oral anticoagulation for stroke prevention in atrial fibrillation: A meta-analysis of randomized controlled trials. Indian Journal of Cardiology. 2026;29(1):68-78. doi:10.4103/ijoc.ijoc_15_26

BibTeX
@article{Mondal2026,
  author = {Mondal, Avilash and Thangjui, Sittinun and Challa, Abhiram and Kaur, Banveet and Hamza, Syed Mufarrih and Truong, Vien and Taha, Amro and Thyagaturu, Harshith and Chilingarashvili, Giorgi and Bailey, Alison and Munir, Muhammad Bilal and Schwartzman, David and Balla, Sudarshan},
  title = {Left atrial appendage occlusion versus oral anticoagulation for stroke prevention in atrial fibrillation: A meta-analysis of randomized controlled trials},
  journal = {Indian Journal of Cardiology},
  year = {2026},
  volume = {29},
  number = {1},
  pages = {68--78},
  doi = {10.4103/ijoc.ijoc_15_26}
}
Kostenlos starten →